“…Several decades later, the first drug delivery systems were developed, containing active medical substances attached to the surface of a carrier or encapsulated within the carrier which possesses specific cell affinity contained within molecular vectors and would disintegrate and release the capsulated drug upon contact with diseased cells [155][156][157]. Organic nanosystems (liposomes, micelles, polymer NPs) [158][159][160] together with carbon nanotubes and fullerene NPs [161][162][163] are the most often employed drug carriers, while different hormones, enzymes, peptides, antibodies, and viruses often serve as molecular vectors [164][165][166][167]. Thus far, the available carriers and capsules for targeted drug delivery have each shown several disadvantages, from limited chemical and mechanical stability of organic NPs, over the questionable toxicity of carbon-based systems, to the general susceptibility to microbiological attack, lack of control over the carrier movement and the rate of drug release, and, finally, high cost [168][169][170][171].…”